MAPLES-DR: MESSIDOR Anatomical and Pathological Labels for Explainable Screening of Diabetic Retinopathy

Gabriel Lepetit-Aimon,Clément Playout,Marie Carole Boucher,Renaud Duval,Michael H Brent,Farida Cheriet
2024-01-20
Abstract:Reliable automatic diagnosis of Diabetic Retinopathy (DR) and Macular Edema (ME) is an invaluable asset in improving the rate of monitored patients among at-risk populations and in enabling earlier treatments before the pathology progresses and threatens vision. However, the explainability of screening models is still an open question, and specifically designed datasets are required to support the research. We present MAPLES-DR (MESSIDOR Anatomical and Pathological Labels for Explainable Screening of Diabetic Retinopathy), which contains, for 198 images of the MESSIDOR public fundus dataset, new diagnoses for DR and ME as well as new pixel-wise segmentation maps for 10 anatomical and pathological biomarkers related to DR. This paper documents the design choices and the annotation procedure that produced MAPLES-DR, discusses the interobserver variability and the overall quality of the annotations, and provides guidelines on using the dataset in a machine learning context.
Image and Video Processing,Databases,Quantitative Methods
What problem does this paper attempt to address?
The main problem addressed in this paper is to improve the interpretability of automated diagnosis for diabetic retinopathy (DR) and macular edema (ME). Existing machine learning models perform well in DR screening but lack interpretability, which leads to low trust from the medical community. To address this issue, the research team created a new dataset called MAPLES-DR, which includes 198 images from the MESSIDOR public fundus image dataset with new diagnoses (DR and ME) and pixel-level segmentation maps of 10 anatomical and pathological biomarkers related to DR. The creation of the MAPLES-DR dataset aims to provide richer and clinically relevant training labels to support model learning with representation compatible with clinical knowledge and facilitate the interpretability of the model in the future. The paper describes in detail the design choices, annotation process, potential biases, and inaccuracies of the dataset, and provides guiding principles for using the dataset in machine learning. By providing pixel-level structural annotations, the researchers hope to drive the development of interpretable DR screening models.